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Abstract
The incidence of dengue fever and dengue hemorrhagic fever in Brazil experienced a significant increase since the
emergence of dengue virus type-3 (DENV-3) at the early 2000s. Despite the major public health concerns, there have been
very few studies of the molecular epidemiology and time-scale of this DENV lineage in Brazil. In this study, we investigated
the origin and dispersion dynamics of DENV-3 genotype III in Brazil by examining a large number (n = 107) of E gene
sequences sampled between 2001 and 2009 from diverse Brazilian regions. These Brazilian sequences were combined with
457 DENV-3 genotype III E gene sequences from 29 countries around the world. Our phylogenetic analysis reveals that there
have been at least four introductions of the DENV-3 genotype III in Brazil, as signified by the presence of four
phylogenetically distinct lineages. Three lineages (BR-I, BR-II, and BR-III) were probably imported from the Lesser Antilles
(Caribbean), while the fourth one (BR-IV) was probably introduced from Colombia or Venezuela. While lineages BR-I and BR-
II succeeded in getting established and disseminated in Brazil and other countries from the Southern Cone, lineages BR-III
and BR-IV were only detected in one single individual each from the North region. The phylogeographic analysis indicates
that DENV-3 lineages BR-I and BR-II were most likely introduced into Brazil through the Southeast and North regions around
1999 (95% HPD: 1998–2000) and 2001 (95% HPD: 2000–2002), respectively. These findings show that importation of DENV-3
lineages from the Caribbean islands into Brazil seems to be relatively frequent. Our study further suggests that the North
and Southeast Brazilian regions were the most important hubs of introduction and spread of DENV-3 lineages and deserve
an intense epidemiological surveillance.
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Introduction
Dengue virus (DENV) is a member of the genus Flavivirus, family
Flaviviridae, and one of the most important arboviral pathogens.
The single-stranded positive-sense genomic RNA encodes one
large open reading frame (ORF) as a polyprotein, which
undergoes proteolytic processing into three structural proteins:
capsid (C), membrane (M) and envelope (E); and seven non-
structural proteins: NS1, NS2A, NS2B, NS3, NS4A, NS4B and
NS5. DENV is transmitted to humans through the bites of infected
Aedes mosquitoes, principally A. Aegypti, which is widely distributed
around the tropical and subtropical regions of the world [1].
Infection with DENV causes a wide spectrum of disease
manifestations, ranging from unapparent infection to severe and
potentially fatal disease [2].
There are four distinct antigenic groups or serotypes of DENV
(DENV-1 to DENV-4) that are causing human pandemics. A
number of phylogenetically distinct lineages, termed genotypes,
have been also identified within each serotype, which may differs in
both geographical distribution and viral virulence/transmissibility
[3,4,5]. Among them, the genotype III of DENV-3 has been
frequently associated with severe dengue outbreaks in Asia, Africa
and Latin America [6,7,8,9,10,11,12,13,14,15,16,17,18]. DENV-3
genotype III probably emerged in the Indian sub-continent around
the middle 1970s and subsequently spread to other countries from
Asian, Africa and the Americas [6,19]. This genotype was first
detected in the Americas during dengue fever/dengue hemorrhagic
fever (DF/DHF) outbreaks in Nicaragua and Panama, in 1994
[20,21]. In the following years the virus spread through the region
using several independent routes from Central America and Mexico
to the Caribbean and South America [18,19,22].
In Brazil, millions of dengue infections have been detected all
over the country since 1986 [23]. The first autochthonous case of
DENV-3 (genotype III) was reported in December 2000 in the
state of Rio de Janeiro (Southeast region), from a patient with
dengue fever [24]. During the summer of 2002, the newly
introduced DENV-3 serotype caused one of the largest dengue
outbreaks in the state of Rio de Janeiro, infecting a susceptible
population that had only experienced DENV-1 and DENV-2
epidemics. In the first half of the 2002, the state reported 288,245
dengue cases, including 1.831 DHF cases and 91 deaths; which
exceed the total number of DHF cases reported in Brazil from
1986 to the time of the epidemic [25]. Subsequent outbreaks of
DENV-3 continued to be documented through the 2000s in Rio
de Janeiro as well as in almost all Brazilian territory, revealing the
rapid spread of this new serotype in the country.
Despite the public health importance of DENV-3 genotype III
in Brazil, there have been very few studies of the molecular
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epidemiology of this DENV genotype in the country. The first
study surveyed the phylogenetic diversity of a small number
(n = 19) of Brazilian DENV-3 genotype III E gene sequences
collected up to 2004 [16]; while two more recent studies have
focused on the analysis of localized dengue outbreaks occurring in
the state of Sao Paulo during 2006 [26,27]. This prompted us to
perform a more comprehensive study to investigate the origin,
evolution, and dispersion dynamics of DENV-3 genotype III in
Brazil by examining a large number (n = 107) of E gene sequences




Virus isolates were derived from human serum specimens
obtained from 19 Brazilian patients with confirmed dengue virus
type 3 (DENV-3) infection from Rio de Janeiro (n = 12), Espirito
Santo (n = 3) and Goias (n = 4) states (Table 1). The case-patients
included in this study had acute febrile illness with two or more of
the following clinical manifestations: headache, retrobulbar pain,
myalgia, arthralgia, rash and hemorrhage. Ethical clearance was
obtained with the approval resolution number CSN196/96 from
the Oswaldo Cruz Foundation Ethical Committee in Research
(CEP 274/05), and all subjects provided written informed consent
before participation. All samples were received refrigerated and
stored at 270uC until tested. The viruses were isolated by
inoculation into Aedes albopictus C6/36 cell lines [28] and the
serotype was identified by indirect immunofluorescence using
type-specific monoclonal antibodies [29].
Viral RNA extraction, amplification, and sequencing of E
gene region
Viral RNA was extracted from 140 mL of cell culture
supernatant by use of the QIAamp Viral RNA Mini Kit
(QIAGEN, Valencia, CA), according to the manufacturer’s
instructions. The complete E gene (1479 bp in length) was then
amplified by reverse transcription-PCR (RT-PCR) as described
previously [30]. Amplicons were directly sequenced in both
directions using a BigDye Terminator Cycle Sequencing Ready
Reaction kit (Applied Biosystems, US), 1 mM of primers combined
with 200 ng of DNA, after purification using PCR purification kit
(Qiagen, US). Thermocycling conditions consisted of 30 cycles of
94uC for 1 min, 60uC for 2 min and 72uC for 3 min. After
purification using Centri-Sep columns (Applied Biosystems, US)
the DNA was dried at 37uC, overnight. The pellet was
resuspended in 10 ml of Hi-Di Formamide (Applied Biosystems,
US), heated for 2 min at 95uC and kept on ice until 10 ml was
loaded on an Applied Biosystems Prism 3730 Sequencer (Applied
Biosystems, US).
Sequence dataset
The sequences generated here were combined with all DENV-3
genotype III complete E gene sequences available at the GenBank
by July 2010, from which the country and year of isolation were
available. One sequence from Mozambique (GenBank accession
FJ882575) previously identified as inter-genotype recombinant and
two sequences from Brazil (GenBank accession FJ898446 and
FJ898447), from which no information about country region was
Table 1. DENV-3 data set.
Region Country N Sampling dates















Caribbean Anguilla 1 2001
Cuba 3 2000–2002
Martinique 6 1999–2001
Puerto Rico 93 1998–2007
Saint Lucia 2 2001
Trinidad and Tobago 2 2002





Sri Lanka 15 1981–2000
Taiwan 1 2006
Middle-West Saudi Arabia 5 1997/2004
Africa Somalia 1 1993
South Pacific American Samoa 1 1986
doi:10.1371/journal.pntd.0001784.t001
Author Summary
Dengue is a major health problem in the tropics and the
incidence of dengue fever and dengue hemorrhagic fever
in Brazil experienced a significant increase since the
emergence of dengue virus type-3 (DENV-3). In this study,
the authors reconstruct the spatio-temporal dispersion
pattern of the DENV-3 lineage that circulates in Brazil and
the Americas. The authors found that DENV-3 outbreaks
occurring in the American continent since the mid-1990s
are the result of a single introduction of genotype III. The
Central American countries and Mexico were the hubs of
genotype III spread in the Americas, while the Caribbean
region acted as a staging post between Central America/
Mexico and South America. The authors estimate that
there have been at least four introductions of the DENV-3
genotype III in Brazil, although only two of them
succeeded in getting established and disseminating
through the country. The Lesser Antilles (Caribbean) were
the main source of DENV-3 viruses that arrived into Brazil,
and the North and Southeast country regions seem to be
most important hubs of introduction and dissemination of
DENV-3 lineages. These findings offer important informa-
tion to perform more effective surveillance programs to
detect introduction and dispersal of new DENV lineages in
Brazil.
DENV-3 in Brazil
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available, were excluded from the analysis. We also excluded four
sequences that displayed anomalously long branches in the
phylogenetic analysis: one from Brazil (GenBank accession
AY038605), one from Puerto Rico (GenBank accession
EU529696) and two from Argentina (GenBank accession
EU052792 and EU052792) (data not shown). This resulted in a
final data set of 564 DENV-3 genotype III E sequences (1,479 nt
long) from the Americas (n = 469), Asia (n = 88), Middle-West
(n = 5), South Pacific (n = 1) and Africa (n = 1), covering a total of
29 countries (Table 1). Nucleotide sequences were aligned using
CLUSTAL X program [31]. Alignment is available from the
authors upon request.
Phylogenetic analysis
Phylogenetic analyses were performed under the GTR+I+C4
model of nucleotide substitution, selected using the jModeltest
program [32]. A Maximum Likelihood (ML) phylogenetic tree was
inferred for the complete data set of 566 DENV-3 genotype III E
sequences with PhyML program [33], using an online web server
[34]. Heuristic tree search was performed employing the SPR
branch-swapping algorithm and the reliability of the phylogenies
was estimated with the approximate likelihood-ratio test (aLRT)
based on a Shimodaira–Hasegawa-like procedure. A Bayesian
phylogenetic tree was inferred for a subset of 202 DENV-3
sequences using MrBayes program [35]. Chains were run for
106106 generations and convergence of parameters was assessed
by calculating the Effective Sample Size (ESS) using TRACER
v1.5 program [36], after excluding an initial 10% for each run. All
parameter estimates for each run showed ESS values .100.
Analysis of spatio-temporal dispersion pattern
The rate of nucleotide substitution per site per year (subs./site/
year), the time to the most recent common ancestor (Tmrca) and
the spatial diffusion of a given DENV-3 lineage were jointly
estimated using the Bayesian Markov chain Monte Carlo
(MCMC) statistical framework implemented in the BEAST
v1.6.1 package [37,38]. A matrix of geographic locations was
constructed based on the place of sampling for each sequence. A
full model was used in which all possible reversible exchange rates
between locations were equally likely (flat prior) [39]. Where two
discrete locations were grouped together, the longitude and
latitude used were those of the midpoint of the line connecting
them. Where more than two locations were grouped, the latitude
and longitude of the centroid of the polygon defined by them were
used. Analyses were carried out with a Bayesian Skyline coalescent
tree prior [40], under the GTR+I+C4 model of nucleotide
substitution and using a relaxed (uncorrelated Lognormal) [41]
molecular clock model. The MCMC analysis was run for 106107
generations and convergence of parameters (ESS.200) was
assessed with TRACERv1.5 program as described above.
Uncertainty in parameter estimates was reflected in the 95%
highest probability density (HPD) intervals. The programs
TreeAnnotator v1.5.2 and FigTree v1.1.2 (http://tree.bio.ed.ac.
uk/software/figtree/) were used to summarize the posterior tree
distribution and to visualize the annotated maximum clade
credibility (MCC) tree, respectively.
Results
Diversification of DENV-3 genotype III in the Americas
The phylogenetic analysis of 564 DENV-3 genotype III E gene
sequences sampled world-wide revealed that all American strains
segregate in a monophyletic cluster (Fig. 1), suggesting a single
introduction of this genotype into the continent, consistent with
previous findings [6,19]. The only sequence of African origin
included in our data set, which correspond to a virus isolated in
Somalia in 1993 (GenBank accession DQ341208), branched
between Asian and American strains (Fig. 1), supporting an
scenario in which DENV-3 genotype III may have gone from Asia
into Africa, and then into the Americas [6,19].
Inside the DENV-3 genotype III American cluster, strains
isolated in Central America (from 1994 to 1998) and Mexico (from
1995 to 2007) branched close to the root of the cluster, while
sequences isolated in the Caribbean (from 1998 to 2007) and
South America (from 2000 to 2009) segregate in three different
monophyletic sub-clusters (Fig. 1). This pattern support the view
that DENV-3 genotype III was introduced into Central America
or Mexico and from there spread to the Caribbean and South
America following three major routes. In the first route the virus
spread to Puerto Rico, Venezuela and Colombia, producing the
lineage Caribbean/South America I, which also includes one
sequence isolated in Brazil (Fig. 2a). In the second route the virus
disseminated into the Pacific side of South America hitting Peru,
Ecuador and Colombia, and subsequently moved back to
Venezuela, Cuba, Puerto Rico and Nicaragua; constituting the
lineage Caribbean/South America II (Fig. 2b). In the third route
the virus went to the Caribbean (Martinique, Puerto Rico, Cuba,
Trinidad and Tobago, Saint Lucia and Anguilla) and from there
into the Southern Cone of South America (Brazil, Argentina,
Bolivia and Paraguay), originating the lineage Caribbean/South
America III, which also included one sequence from Guyana and
another one from Venezuela (Fig. 2c).
Diversification of DENV-3 genotype III in Brazil
To analyze the diversity of DENV-3 in Brazil in more detail, we
undertook a more rigorous Bayesian phylogenetic analysis of a
subset of 202 DENV-3 genotype III sequences which combine all
sequences sampled from Brazil (n = 107), along with selected non-
Brazilian ‘background’ sequences (n = 95). DENV-3 Brazilian
sequences were sampled from the Southeast (n = 74), North
(n = 20), Central-West (n = 8) and Northeast (n = 5) regions (Fig. 3
and Table S1). DENV-3 non-Brazilian background sequences
comprise all genotype III sequences from the lineage Caribbean/
South America III (n = 54) and representative sequences from Asia
(n = 10), Africa (n = 1), Central America and Mexico (n = 10),
lineage Caribbean/South America I (n = 10), and lineage Carib-
bean/South America II (n = 10).
The DENV-3 genotype III Brazilian sequences analyzed were
distributed in four independent lineages, revealing at least four
Figure 1. ML tree of 564 DENV-3 genotype III E gene sequences circulating globally. Brackets indicate clades comprised of sequences
sampled from Asia, Africa and the Americas. Taxon labels include reference to country of isolation, year of isolation, and GenBank accession number.
Country represented are American Samoa (AS), Bangladesh (BD), Bhutan (BT), China (CH), Honduras (HN), India (IN), Malaysia (MY), Mexico (MX),
Nicaragua (NI), Panama (PA), Saudi Arabia (SA), Singapore (SG), Somalia (SO), Sri Lanka (LK), Taiwan (TW). For visual clarity, supported clades
comprised of sequences sampled from Caribbean/South America (see Fig. 2), Bhutan and Singapore has been collapsed. Only aLTR support values
.80 are shown. All horizontal branch lengths are drawn to a scale of nucleotide substitutions per site. The tree was rooted using DENV-3 genotype I
strains. UP (Unidentified Place).
doi:10.1371/journal.pntd.0001784.g001
DENV-3 in Brazil
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Figure 2. Sub-trees corresponding to the Caribbean/South America clades I (a), II (b) and III (c). The color of a tip branch represents the
geographic region from where the strain originated, according to the legend given in the figure. Numbers in the legend represent the sampling date
of sequences. For visual clarity, some clades composed by sequences from the same country/region are schematically represented by triangles. All
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introduction events of this DENV-3 genotype in the country
(Fig. 4). Most Brazilian sequences (n = 92; 86%) grouped in a well
supported monophyletic clade (PP = 0.86) within the Caribbean/
South America III cluster, called BR-I; which contains sequences
sampled from all Brazilian regions from 2001 to 2009, along with
sequences isolated in Argentina, Bolivia and Paraguay. A minor
proportion of Brazilians sequences (n = 13; 12%) isolated in the
North region from 2003 to 2008 and Sao Paulo state (Southeast
region) in 2006, segregate in a second monophyletic clade (PP = 1)
within the Caribbean/South America III lineage, called BR-II;
which also includes sequences isolated in Paraguay and Argentina.
The third Brazilian lineage is represented by a single isolate
sampled in the state of Roraima (North region) in 2002 (GenBank
accession DQ118865), which formed a monophyletic cluster
(PP = 1) with sequences from several Caribbean Islands within
the Caribbean/South America III clade. The fourth Brazilian
lineage also correspond to a single sequence isolated in the North
region at 2003 (GenBank accession FJ850079), that is closely
related to Venezuelan and Colombian sequences from clade
Caribbean/South America I.
Most DENV-3 Brazilian sequences included in the present
study were retrieved from Sao Paulo (N = 58; 54%) and Rio de
Janeiro (N = 13; 12%), which are the most populated states of the
country. A closer inspection of those DENV-3 strains reveals a
significant difference in the pattern of viral dissemination within
these regions. While nearly all sequences isolated in Rio de Janeiro
from 2002 to 2008 segregate in a single monophyletic cluster (BR-
RJ), sequences sampled in Sao Paulo split in three major
independent lineages: BR-SP-I (from 2003 to 2007), BR-SP-II
(from 2006 to 2009) and BR-SP-III (at 2006) (Fig. 4). Furthermore,
sequences sampled in Sao Paulo were closely related to Brazilian
sequences isolated in the Central-West (BR-SP-I, BR-SP-II) and
North (SP-III) regions; while sequences from Rio de Janeiro
showed a closer relationship with sequences isolated in the states of
Espirito Santo (Southeast region) and Pernambuco (Northeast
region) (Fig. 4). A few DENV-3 sequences from Rio de Janeiro and
Sao Paulo branched outside the major clades and possibly
represent viruses that did not succeed in getting established in
those regions.
Origin and time-scale of DENV-3 clades BR-I and BR-II
In order to gain insight into the place and timing of introduction
of major DENV-3 Brazilian lineages (BR-I and BR-II), we used a
Bayesian MCMC phylogeographic approach that jointly estimates
the substitution rate, the Tmrca and the spatial diffusion from
sampled sequences, while accommodating phylogenetic uncer-
tainty arising from the sequence data. DENV-3 sequences from
clades BR-I and BR-II were combined with Caribbean DENV-3
sequences from lineage Caribbean/South America III and with
DENV-3 sequences isolated in Central America at the middle
1990s. A specific ‘‘character state’’ was assigned to each DENV-3
sequence based on its geographic origin, according to the
following scheme: Central America (Panama, Nicaragua, and
Honduras), Greater Antilles (Puerto Rico and Cuba), Lesser
Antilles (Anguilla, Martinique, Saint Lucia, and Trinidad and
Tobago), South America (Guyana and Venezuela), North Brazil,
Southeast Brazil, Northeast Brazil, and Central-West Brazil.
Analyses were performed under an equal rates model that assumes
the same rate of virus movement between the eight locations.
The mean evolutionary rate and Tmrca of the DENV-3 data-set
were estimated at 11.061024 subs./site/yr (95% HPD: 8.3–
13.861024 subs./site/yr) and 1991 (95% HPD: 1988–1993),
respectively; which are close to those previously reported for the
DENV-3 genotype III in the Americas [19]. The spatio-temporal
reconstruction suggests that the Caribbean/South America III
lineage likely originated in the Lesser Antilles (PP = 75%) at
around 1997 (95% HPD: 1995–1999), and rapidly spread to the
Greater Antilles and South America (Fig. 5). The Brazilian clade
BR-I was probably imported from the Caribbean islands into the
Southeast region (PP = 83%) at around 1999 (95% HPD: 1997–
Figure 3. This map identifies the regions and states that make up Brazil. Legend described the color code and the number of sequences
analyzed from each Brazilian region.
doi:10.1371/journal.pntd.0001784.g003
DENV-3 in Brazil
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2000), while the clade BR-II probably migrated from the
Caribbean islands to the North Brazilian region (PP = 97%) at
around 2001 (95% HPD: 1999–2002) (Fig. 5).
Discussion
The genotype III has established as the major lineage of DENV-
3 in the Americas. The phylogenetic analysis presented here
confirms that DENV-3 outbreaks occurring in the American
continent since the mid-1990s are the result of a single
introduction of genotype III. This analysis also suggest that viral
introduction probably occurs through Central America or Mexico,
and from there the virus spread to the Caribbean and South
America following three major routes, giving rise to three
independent evolutionary lineages (Caribbean/South America I
to III), consistent with previous findings [18,19,22]. According to
this model, Central American countries and Mexico were the hubs
of genotype III spread in the Americas, while the Caribbean
region acted as a staging post between Central America/Mexico
and South America. The lack of evidence of dissemination of new
DENV-3 strains in the Americas reveals that despite massive
human movement between continents, the establishment of new
DENV-3 lineages of Asian and/or African origin in the Americas
seems to be an improbable phenomenon. In the last two decades,
the current lineages of DENV-3 circulating in the Americas
immunized ‘‘naturally’’ the population, due to its wide spread in
the continent. This factor may have been decisive to explain the
lack of new introductions of Asian and/or African lineages.
Brazil has been heavily affected by DENV-3 since the early
2000s and our study reveals that there have been at least four
separate introductions of the genotype III into the country, as
signified by the presence of four phylogenetically distinct lineages.
Three lineages (BR-I, BR-II, and BR-III) belong to the
Caribbean/South America III clade and were probably imported
from the Caribbean islands. The fourth lineage (BR-IV) belong to
the Caribbean/South America I clade and was probably
introduced from Colombia or Venezuela; while we found no
evidence of dissemination into Brazil of the Caribbean/South
America II lineage that mainly hits the Pacific side of the Andes
(Peru, Ecuador and Colombia). Recent studies have shown the re-
Figure 4. Majority-rule Bayesian consensus tree representing the global diversity of DENV-3 genotype III. The color of a tip branch
represents the geographic region from where the strain originated, according to the legend given in the figure. Brackets indicate major region-
specific genotype III clades and discrete Brazilian lineages (indicative of separate introductions). Broken boxes highlight subclades of Brazilian
sequences circulating in Rio de Janeiro (RJ) and Sao Paulo (SP) states. Taxon labels include reference to country of isolation, year of isolation, and
GenBank accession number or strain designation. Country represented are: Anguilla (AI), Argentina (AR), Bolivia (BO), Brazil (BR), Cuba (CU), Colombia
(CO), Ecuador (EC), Guyana (GY), Honduras (HN), Martinique (MQ), Mexico (MX), Nicaragua (NI), Panama (PA), Peru (PE), Puerto Rico (PR), Paraguay (PY),
Saint Lucia (SL), Somalia (SO), Sri Lanka (LK), Trinidad and Tobago (TT), and Venezuela (VE). PP values are shown for relevant nodes. All horizontal
branch lengths are drawn to a scale of nucleotide substitutions per site. The tree was rooted using DENV-3 genotype I strains. UP (Unidentified Place).
doi:10.1371/journal.pntd.0001784.g004
Figure 5. Time-scaled Bayesian Maximum Clade Credibility tree for the DENV-3 Caribbean/South America III lineage. Terminal
branches of the tree are colored according to the sampled location of the taxon at the tip. Internal branches are colored according to the most
probable location of their parental node. The age (with 95% HPD in parentheses) and the posterior probabilities for the geographic locations of
parental nodes of the Caribbean/South America III, BR-I and BR-II lineages are shown. Branch lengths of the trees correspond to length of time (see
the time scale bar). The tree is automatically rooted under the assumption of a relaxed molecular clock.
doi:10.1371/journal.pntd.0001784.g005
DENV-3 in Brazil
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introduction into Brazil of a new DENV-2 lineage of the
American/Asian genotype, that is closely related to DENV-2
strains circulating in some Caribbean islands (Martinique, Cuba
and the Dominican Republic) [42,43]. Thus, the Caribbean region
seems to be the main source of new DENV strains introduced into
Brazil.
The final outcome of each DENV-3 introduction into Brazil
was highly variable. The most successful clade was the BR-I. This
lineage comprises 86% of DENV-3 Brazilian sequences analyzed
in the present study, was detected in all country regions from 2001
to 2009, and was also disseminated to other countries from the
Southern Cone (Argentina, Bolivia and Paraguay). The lineage
BR-II comprises 12% of Brazilian sequences and has been
detected in the North region between 2003 and 2008, in Sao Paulo
state (Southeast region) and Paraguay in 2006 and in Argentina in
2007. In contrast with the previous clades, the BR-III and BR-IV
lineages seem to have failed to become established in Brazil, since
both lineages were detected in one single individual each from the
North region at 2002 and 2003, respectively, and none of the later
Brazilian isolates grouped within these clades. The detection of
DENV-3 lineages BR-I and BR-II in Argentina, Bolivia and
Paraguay, points to Brazil as an efficient hub of dissemination of
DENV-3 in the Southern cone.
Our phylogeographic analysis suggests that the most widely
disseminated Brazilian DENV-3 clade (BR-I) probably entered
into the country through the Southeast region. The state of Rio de
Janeiro in the Southeast region is considered as the most important
point for the introduction and dissemination of new DENV strains
in Brazil as this sate was the place where the first cases of DENV-1
(1986), DENV-2 (1990), and DENV-3 (2000) were detected in
Brazil [24]. The states of Rio de Janeiro and Sao Paulo also
displayed among the largest and heavily dense urban population in
the country, contain the most important national and international
airports, and are highly connected to other states trough a large
roadway and railway system. These conditions create an excellent
milieu for introduction and rapid dissemination of new viral
strains. On the other hand, lineages BR-II, BR-III, and BR-IV
were probably introduced through the North Brazilian region.
The close geographic proximity of the Northern states to the
Caribbean region may explain the existence of a considerable
diffusion of DENV-3 lineages across the northern Brazilian
border.
The evolutionary analysis suggests that DENV-3 lineage BR-I
displayed a period of cryptic circulation for about 1–3 years before
its detection by the Brazilian public surveillance network.
According to our estimates the BR-I clade emerged around
1999 (95% HPD: 1997–2000); but its presence was first reported
in Rio de Janeiro at December 2000. In agreement with our
findings, Romano et al [43] estimated that the new DENV-2
lineage detected in Rio de Janeiro at 2007 was introduced in the
country at least 2–3 years earlier. Our analysis also supports that
DENV-3 clades BR-I and BRII were disseminated at a very fast
rate throughout Brazil. The reconstructed spatio-temporal pattern
of DENV-3 dissemination indicates that lineages BR-I and BR-II
emerged at around 1999 and 2001 in the Southeast and North
regions, respectively; and only a few years later (2002–2006) both
lineages were detected in regions located almost 5,000 km away. A
similar finding was recently observed for DENV-4 that, after an
absence of 30 years, was detected in Roraima state (North region)
in July 2010 and only eight months later the virus was detected in
several states of the Northeast and Southeast regions [44].
This study also points to the existence of a non-random pattern
of DENV-3 dissemination across Brazilian regions, and further
reveals significant differences in the molecular profile of DENV-3
epidemics occurring at the two most populated states of the
country, Sao Paulo and Rio de Janeiro. The DENV-3 epidemics
occurring in Sao Paulo state during the 2000s were seeded by the
introduction and co-circulation of at least three viral strains (BR-
SP-I, BR-SP-II, and BR-SP-III), consistent with previous obser-
vations [26,27]. By contrast, the successive DENV-3 outbreaks
taking place in Rio de Janeiro over the last decade were the result
of the long-term persistence and in situ evolution of a single viral
lineage (BR-RJ). Those DENV-3 strains detected in Sao Paulo
were closely related to DENV-3 strains circulating in the Central-
Western and Northern Brazilian regions. While, the BR-RJ
lineage circulates in the states of Espirito Santo (Southeast region)
and Pernambuco (Northeast region). Of note, despite the intense
movement of people, high geographic proximity and dense viral
sampling, we found no evidence of an important DENV-3 flux
between Sao Paulo and Rio de Janeiro.
In conclusion, our study demonstrates that there have been at
least four introductions of the same DENV-3 genotype III in
Brazil, although only two viral lineages seems to have become
efficiently established and disseminated in the country. The
Caribbean islands were the main source of DENV-3 viruses that
arrived into Brazil, and the Northern and Southeastern Brazilian
regions seems to be most important hubs of introduction and
dissemination of such DENV-3 lineages. Our analyses also suggest
that DENV-3 strains circulated for at least 1–2 years until meet
favorable conditions to initiate an outbreak and to be detected by
the Brazilian public surveillance system. Continuous epidemiolog-
ical surveillance and dense sequencing of viral strains circulating in
all Brazilian regions are of paramount importance to early
detection of newly emerging DENV lineages, to understanding
the patterns of DENV dissemination across country regions, and
to guide the actions for dengue control programs in Brazil.
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dos Santos, PhD, and Márcia Gonçalves de Castro, PhD, who were
generous with their time and advice. We also thank Eliane Araújo,
Monique Lima, Jaqueline Bastos, Nieli Faria, José Farias, Leda Santos,
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